Did You Know...
...that Kleenex tissue was originally designed to be a gas mask filter? It was developed at the beginning of World War I to replace cotton, which was then in short supply as a surgical dressing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8022279 | Liposomal formulations of anthracycline agents and cytidine analogs Compositions which comprise an anthracycline agent, and a cytidine analog are encapsulated in liposomal carriers. The preferred anthracycline agent is selected from the group of daunorubicin, doxorubicin, and idarubicin, while the preferred cytidine analog is select... | 09/20/2011 |
| 7438903 | Methods and compositions that enhance bioavailability of coenzyme-Q10 Bioavailability of Coenzyme-Q10 (“Co-Q10”), an oil-soluble substance, can be enhanced in a subject by modifying, e.g. nanonizing or charging, the form of Co-Q10. Co-Q10 bioavailability also can be enhanced by administering Co-Q10 to the subject as an oil (lipid)... | 10/21/2008 |
| 7371738 | Method of transdermal drug delivery using hyaluronic acid nanoparticles The present invention relates to the development of a hyaluronic acid and hyaluronic acid hybrid nanoparticle systems for the administration of active molecules, peptides, DNA and/or other hydrophilic or hydrophobic molecules, the composition of hyaluronic acid and ... | 05/13/2008 |
| 7329807 | High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them The present invention relates to novel fusogenic vesicles as highly efficient and versatile encapsulation systems for delivering a substance of choice, such as nucleic acids, proteins, peptides, antigens, pharmaceutical drugs and cosmetic agents to cells and tissues... | 02/12/2008 |
| 6661691 | Interconnection structure and methods Interconnection structures for integrated circuits have a first array of cells, at least a second array of cells parallel to the first array, and interconnections disposed for connecting cells of the first array with cells of the second array, at least so... | 12/09/2003 |
| 6647980 | Method for administration of active substances to the olfactory region The present invention relates to a method for administering a pharmaceutical preparation comprising at least one active substance to the olfactory region of a human. The method comprises administering a unit dose of the preparation by ejection from a nasa... | 11/18/2003 |
| 6642273 | Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and in cosmetics An unsaturated derivative at the 4-position of 6-tert-butyl-1,1-dimethylindane corresponding to the following formula: ##STR1## in which: X represents: a divalent radical of formula: ##STR2## and Y represents a divalent radical of following formul... | 11/04/2003 |
| 6616926 | Methods of modulating lipid metabolism and storage Anti-hedgehog antibodies directed at blocking the binding of hedgehog to its receptor patched-1, will impair lipid metabolism and storage. This invention presents methods for the treatment of a variety of lipid metabolism and lipid storage disorders, aber... | 09/09/2003 |
| 6245349 | Drug delivery compositions suitable for intravenous injection The present invention provides drug delivery compositions in both concentrated and diluted forms for use as vehicles in the administration of various active agents. The drug delivery compositions are primarily designed for use with lipophilic, amphipathic... | 06/12/2001 |
| 6241967 | Process and device for the production of liquid, disperse systems A continuous process for the production of liquid, disperse systems is described, which is characterized in that a predispersion is extruded under a high pressure of 6.6 to 250 MPa sequentially over 1 to 8 filter stages of decreasing pore size between 0.0... | 06/05/2001 |
| 4745160 | Biodegradable amphipathic copolymers A pharmaceutically or veterinarily acceptable amphipathic, non-cross linked linear, branched or graft block copolymer, which has a minimum weight average molecular-weight of 1000, in which the hydrophobic component is biodegradable or hydrolytically unsta... | 05/17/1988 |
